Selective sPlenic flExure Mobilization for Low colorEctal Anastomosis After D3 lYmph Node Dissection (Speedy Trial)
SpeeDy
Randomized Non-inferiority Trial of Selective Splenic Flexure Mobilization for the Formation of Low Colorectal Anastomosis After Total Mesorectal Excision and D3 Paraaortic Lymph Node Dissection in Low Rectal Cancer.
1 other identifier
interventional
142
1 country
1
Brief Summary
In the Low Anterior Resection of rectum for cancer, the section level of IMA and the need of SFM is still debated. The aim of this study is to explore the different impacts of high and low ligation with peeling off vascular sheath of inferior mesenteric artery (IMA) in low anterior resection of the rectum for cancer. This study purpose to demonstrate that low IMA ligation, sparing of left colic artery (LCA) and selective SFM results in higher anastomotic leakage rate than high IMA ligation with routine SFM (with the difference of more than 5%).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2016
CompletedFirst Submitted
Initial submission to the registry
March 28, 2019
CompletedFirst Posted
Study publicly available on registry
March 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 2, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 2, 2021
CompletedFebruary 27, 2020
February 1, 2020
3.6 years
March 28, 2019
February 26, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anastomotic Leakage Rate
The rate of symptomatic and asymptomatic colorectal anastomotic leakage
4-6 weeks
Secondary Outcomes (11)
Operating time
1 day
Intraoperative complications rate
1 day
Splenic flexure mobilization rate
1 day
Conversion rate
1 day
IMA architectonics
1 day
- +6 more secondary outcomes
Study Arms (2)
IMA high ligation with routine SFM
ACTIVE COMPARATORInferior mesenteric artery is ligated close to its origin. Splenic flexure is always mobilized.
IMA skeletonization and low ligation with selective SFM
EXPERIMENTALInferior mesenteric artery is ligated below the origin of left colic artery. Splenic flexure is mobilized only if needed.
Interventions
Nerve-sparing paraaortic lymph node dissection is performed. The inferior mesenteric artery is divided at 1-2 cm from its origin from the aorta. Nerve-sparing total mesorectal excision is performed. Splenic flexure is mobilized. Side-to-end sigmoido-rectal anastomosis is created.
Nerve-sparing paraaortic lymph node dissection is performed. Then inferior mesenteric artery is skeletonized down to the origin of left colic artery and divided below it. Nerve-sparing total mesorectal excision is performed. Splenic flexure is mobilized only if sigmoid colon is unsuitable for anastomosis or doesn't reach the rectal stump. Then descending-rectal side-to-end anastomosis is created.
Eligibility Criteria
You may qualify if:
- Histologically proven primary rectal adenocarcinoma located within 15 cm from anal verge not involving internal and/or external sphincter muscle
- Stage I-III
- Elective surgical treatment with TME and primary colorectal anastomosis
- Receive or not receive neoadjuvant radio-chemotherapy
- Overall health status according to American Society of Anesthesiologists (ASA) classification: I-III
- Signed informed consent with agreement to attend all study visits
- The patient is not pregnant
You may not qualify if:
- Unresectable tumour, inability to perform a TME with colorectal anastomosis, inability to complete R0 resection or presence of T4b tumour necessitating a multi-organ resection
- The patient wants to withdraw from the clinical trial
- Loss to follow-up
- Inability to complete all the trial procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinic of Colorectal and Minimally Invasive Surgery
Moscow, 119435, Russia
Related Publications (6)
Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986 Jun 28;1(8496):1479-82. doi: 10.1016/s0140-6736(86)91510-2.
PMID: 2425199RESULTHo YH. Techniques for restoring bowel continuity and function after rectal cancer surgery. World J Gastroenterol. 2006 Oct 21;12(39):6252-60. doi: 10.3748/wjg.v12.i39.6252.
PMID: 17072945RESULTKanemitsu Y, Hirai T, Komori K, Kato T. Survival benefit of high ligation of the inferior mesenteric artery in sigmoid colon or rectal cancer surgery. Br J Surg. 2006 May;93(5):609-15. doi: 10.1002/bjs.5327.
PMID: 16607682RESULTLange MM, Buunen M, van de Velde CJ, Lange JF. Level of arterial ligation in rectal cancer surgery: low tie preferred over high tie. A review. Dis Colon Rectum. 2008 Jul;51(7):1139-45. doi: 10.1007/s10350-008-9328-y. Epub 2008 May 16.
PMID: 18483828RESULTMouw TJ, King C, Ashcraft JH, Valentino JD, DiPasco PJ, Al-Kasspooles M. Routine splenic flexure mobilization may increase compliance with pathological quality metrics in patients undergoing low anterior resection. Colorectal Dis. 2019 Jan;21(1):23-29. doi: 10.1111/codi.14404. Epub 2018 Sep 29.
PMID: 30184316RESULTKatory M, Tang CL, Koh WL, Fook-Chong SM, Loi TT, Ooi BS, Ho KS, Eu KW. A 6-year review of surgical morbidity and oncological outcome after high anterior resection for colorectal malignancy with and without splenic flexure mobilization. Colorectal Dis. 2008 Feb;10(2):165-9. doi: 10.1111/j.1463-1318.2007.01265.x. Epub 2007 May 16.
PMID: 17506796RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Petr Tsarkov, Prof
Russian Society of Colorectal Surgeons
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2019
First Posted
March 29, 2019
Study Start
October 2, 2016
Primary Completion
May 2, 2020
Study Completion
November 2, 2021
Last Updated
February 27, 2020
Record last verified: 2020-02